Table 3.

Effects of single EEM administration on glycogen and TG contents in liver and skeletal muscle of normal and diabetic mice.

Group	Liver		Skeletal muscle
	Glycogen (mg/g)	TG (μmol/g)	Glycogen (mg/g)	TG (μmol/g)
Normal control	12.73 ± 0.89	3.40 ± 0.22	1.69 ± 0.16	0.116 ± 0.005
Normal + 2 g/kg EEM	12.58 ± 0.91	3.40 ± 0.20	1.67 ± 0.12	0.115 ± 0.005
Normal + 4 g/kg EEM	12.46 ± 0.74	3.47 ± 0.29	1.65 ± 0.06	0.117 ± 0.006
Normal + 8 g/kg EEM	12.57 ± 0.96	3.44 ± 0.31	1.69 ± 0.12	0.115 ± 0.007
Normal + glibenclamide	12.66 ± 0.96	3.40 ± 0.35	1.68 ± 0.15	0.111 ± 0.010
Diabetic control	6.77 ± 0.55*	5.17 ± 0.26*	2.89 ± 0.20*	0.215 ± 0.017*
Diabetic + 2 g/kg EEM	6.99 ± 0.60	5.27 ± 0.48	2.89 ± 0.21	0.213 ± 0.016
Diabetic + 4 g/kg EEM	7.04 ± 0.55	5.35 ± 0.39	2.72 ± 0.21	0.219 ± 0.013
Diabetic + 8 g/kg EEM	7.20 ± 0.35	5.28 ± 0.40	2.73 ± 0.36	0.201 ± 0.014
Diabetic + glibenclamide	7.18 ± 0.56	5.25 ± 0.35	2.76 ± 0.28	0.199 ± 0.013

Data are expressed as mean ± SD, n = 10 mice per group. *P < 0.01 when compared to normal control.